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Rationale: Home oxygen is the most expensive equipment item that Medicare
purchases ($1.7 billion/year).
Objectives: To assess geographic differences in supplemental oxygen use.
Methods: Retrospective cohort analysis of oxygen claims for a 20% random
sample of Medicare patients hospitalized for obstructive lung disease in 1999
and alive at the end of 2000.
Measurements and Main Results: While 33.7% of the 34,916 hospitalized
patients used supplemental oxygen, there was more than a 4-fold difference
between states and a greater than 6-fold difference between hospital referral
regions with high/low utilization. Rocky Mountain States and Alaska had the
highest utilization, while the District of Columbia and Louisiana had the low-
est utilization. After adjusting for patient characteristics and elevation, high-
utilization communities included low-lying areas in California, Florida, Michi-
gan, Missouri, and Washington. Patients who were younger, male, white, and
who had more comorbidities, more hospital admissions, and lived at higher
altitudes and in areas of greater income also had higher odds of using supple-
mental oxygen. Residing in rural areas was associated with higher unadjusted
oxygen use rates. After adjustment, patients living in large rural areas had
higher odds of using oxygen than patients living in urban areas or in small
rural areas.
Conclusions: There is significant geographic variation in supplemental oxy-
gen use, even after controlling for patient and contextual factors. The Centers
for Medicare & Medicaid Services should examine these issues further and en-
act changes that ensure patient health and fiscal responsibility.
Key words durable medical equipment, health services accessibility, oxy-
gen inhalation therapy, pulmonary disease (chronic obstructive), rural health
services.
Supplemental oxygen significantly improves survival and
quality of life in patients with obstructive lung dis-
ease.1 Its use in the home has been of increased inter-
est as it is the most expensive equipment that Medicare
purchases, costing the program $1.7 billion each year.2
A 1997 study by the Government Accounting Office
found that the Centers for Medicare & Medicaid Services’
(CMS) payment rates for home oxygen were significantly
more than those of the Department of Veterans Affairs.3
As a result, the Government Accounting Office recom-
mended that CMS monitor trends in beneficiaries’ use
of and access to home oxygen systems.4,5 Subsequently,
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CMS has taken several steps to reduce expenditures for
home oxygen, including the Medicare Modernization
Act of 2003, which mandated reductions in Medicare’s
payments.6
However, lost in the desire to reduce oxygen payments
is the potential for differences in beneficiary access based
on geography. Those living at higher elevations may re-
quire supplemental oxygen earlier in the course of their
lung disease because of the decreased amount of oxy-
gen in the atmosphere. In addition, it is well established
that patients in rural areas may utilize less medical care
than those living in urban areas.7,8 Differences in ac-
cess in rural areas may depend upon a number of vari-
ables, including patient-specific factors such as age, race,
ethnicity, and perceptions of quality, as well as extrin-
sic factors, such as insurance coverage and health care
costs.9-12 However, very little is known about the access
of rural residents to durable medical equipment (oxygen,
wheelchairs, and other medical supplies used at home).
Some reports suggest that their access may be worse than
urban residents’ access.13,14
As part of an effort to manage home oxygen use on
the part of CMS, and a more general desire to under-
stand health care utilization behaviors of patients with
obstructive lung disease, we used data from the Medicare
inpatient hospitalization and durable medical equipment
files to assess geographic differences in the use of sup-
plemental oxygen. In addition, we explored the relation-
ships between patient sociodemographic, clinical, and en-
vironmental characteristics on oxygen use. This study is
important because the identification of high or low users
of oxygen is a first step in a quality improvement process
that may reveal communities or populations that require
further investigation and intervention.
Methods
We performed a retrospective cohort analysis of Medicare
patients who were continuously enrolled in Parts A and
B (fee-for-service) Medicare throughout the study period
and were hospitalized for obstructive lung disease be-
tween January 1, 1999, and December 31, 1999. We ex-
cluded those not alive at the end of 2000 as well as those
in Medicare Health Maintenance Organizations, as oxy-
gen utilization data for these patients were unavailable.
Using a 20% random sample of the Medicare Provider
Analysis and Review inpatient file, we identified patients
admitted to acute care hospitals with the primary diag-
nosis of obstructive lung disease or emphysema during
1999. The Medicare Provider Analysis and Review file
contains data from all finalized claims for services pro-
vided to beneficiaries admitted to Medicare-certified in-
patient hospitals. From this file, we selected those indi-
viduals whose primary diagnosis fell into the following
categories: International Classification of Diseases 9th Re-
vision codes 490.0-492.8 and 494.0-496.0. International
Classification of Diseases 9th Revision codes 493.0-493.9
(asthma) were excluded. We chose to define our cohort
using inpatients so that we could select individuals with
severe disease who were likely candidates for supplemen-
tal oxygen. We then searched the Medicare Durable Med-
ical Equipment records for information regarding the sub-
sequent use of supplemental oxygen by these individuals
any time after their hospitalization through the end of
2000. This durable medical equipment file contained in-
formation regarding patient age, gender, race, and home
ZIP code.
We used the home ZIP code of the patient to define
the rural/urban status of the beneficiary. Rural status
was determined by linking this ZIP code to its Rural-
Urban Commuting Area Code (RUCA).15,16 This rural-
urban taxonomy was selected as RUCAs are used in a
wide range of research programs and payment systems.
RUCAs (Version 1.11) describe more refined geographic
units than county-based systems such as the metropoli-
tan, nonmetropolitan taxonomy and include a measure
of commuting relationships. RUCAs differentiate areas
based on their city/town size and work commuting pat-
terns to larger cities and towns. The 30 RUCA designa-
tions were aggregated into 4 categories: Urban (RUCA =
1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 4.1, 5.1, 7.1, 8.1, 10.1), Large
Rural City (in or associated with a large rural city of
10,000 to 49,999 population, RUCA = 4.0, 5.0, 6.0),
Small Rural Town (in or associated with a rural town of
2,500 to 9,999, RUCA = 7.0, 7.2, 7.3, 7.4, 8.0, 8.2, 8.3,
8.4, 9.0, 9.1, 9.2), and Isolated Rural Town (in or asso-
ciated with a rural town of fewer than 2,500, RUCA =
10.0, 10.2, 10.3, 10.4, 10.5). Noncity/town areas were
aggregated with the city/town where they had a strong
commuting relationship.
In addition, we linked the patient’s home ZIP code to
several other databases to estimate 4 other variables: me-
dian household income, elevation above sea level, state,
and hospital referral region (HRR).17 Elevation above sea
level was determined by linking ZIP codes to commer-
cially available data.18 When elevation was missing from
this source, first the 2003 Area Resource File (used for
2.5% of patients) and then the Web-based United States
Geological Survey National Map (used for 0.1% of pa-
tients) were used to obtain elevation.19,20 The patient’s
HRR was 1 of 305 distinct medical care referral regions
across the United States defined by the Dartmouth Atlas of
Health Care.17 Finally, we controlled for patient severity of
illness by determining the number of admissions the pa-
tient had while in the cohort as well as the length of stay
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in the hospital. In order to control for the influence of
comorbid conditions, we applied a modification of Charl-
son’s comorbidity index to each patient.21
Data Analysis
We first described patient sociodemographic characteris-
tics (eg, age, race), clinical characteristics (eg, Charlson
comorbidity index), environmental characteristics (eg,
elevation), and oxygen use by the 4 RUCA types. Stan-
dard statistical tests were employed including overall chi-
square tests and analysis of variance. We then calculated
oxygen use rates in both states and HRRs, identifying
states and HRRs with unadjusted rates of oxygen use that
were more or less than 2 SDs from the corresponding
mean rates of use. We also created a map displaying
the distribution of states’ unadjusted oxygen supplemen-
tation rates using logical breakpoints. Next, we deter-
mined which states and HRRs had high or low utilization
of supplemental oxygen after adjustment for patient so-
ciodemographic, clinical, and environmental variables. In
these multivariate patient-level logistic regression analy-
ses, the dependent variable was occurrence or not of any
patient oxygen claim. We report those states and HRRs
where the odds ratios were greater than 2 SDs above or
below the overall mean odds ratio. Last, we conducted
a multivariate patient-level logistic regression analysis to
identify the association between oxygen use and resi-
dence in different RUCA types.
Results
We identified 35,588 Medicare patients with a hospital-
ization in 1999 who met our study criteria. We excluded
672 (1.9%) patients who were missing at least 1 geo-
graphic identifier (598 without an HRR code and 74 with-
out a RUCA code), leaving 34,916 patients in our final
cohort. Patient characteristics by rural/urban categories
are displayed in Table 1. Of the study patients, 11,766
(33.7%) had a claim for home oxygen between hospital
Table 1 Patient Characteristics by Rural and Urban Residence Location†
Urban Large Rural Small Rural Isolated Small Rural Total
All beneficiaries hospitalized with obstructive lung disease
Number of patients 22,586 4,589 4,319 3,422 34,916
% with oxygen claim∗∗∗ 32.6% 36.8% 34.3% 35.9% 33.7%
Mean number of oxygen claims (SD)∗∗∗ 8.36 (16.8) 9.65 (17.3) 9.42 (17.7) 9.91 (17.7) 8.81 (17.1)
Mean age (SD)∗∗∗ 75.19 (10.9) 74.30 (10.6) 74.52 (10.4) 74.88 (10.6) 74.96 (10.8)
% male∗∗∗ 43.6% 47.9% 47.7% 51.8% 45.5%
% nonwhite∗∗∗ 14.3% 8.1% 7.3% 5.8% 11.8%
Mean number of admissions (SD)∗∗ 1.37 (0.9) 1.35 (0.8) 1.42 (1.0) 1.40 (1.0) 1.38 (0.9)
Mean hospital length of stay in days (SD)∗∗∗ 7.15 (7.9) 6.13 (5.7) 5.68 (4.8) 5.53 (4.9) 6.67 (7.1)
Mean Charlson comorbidity index (SD)∗∗ 1.06 (1.3) 1.04 (1.3) 0.99 (1.3) 1.00 (1.3) 1.04 (1.3)
Mean county elevation in feet (SD)∗∗∗ 581 (855) 988 (1,116) 938 (1,062) 1,069 (1,061) 726 (962)
Mean ZIP code-based median $40,970 ($16,274) $30,446 ($6,827) $27,175 ($6,102) $25,824 ($6,335) $36,396 ($15,021)
household income (SD)∗∗∗
Beneficiaries hospitalized with obstructive lung disease and had an oxygen claim
Number of patients 7,364 1,690 1,483 1,229 11,766
Mean number of oxygen claims (SD)∗∗∗ 25.64 (20.5) 26.21 (19.4) 27.43 (20.4) 27.60 (19.7) 26.15 (20.3)
Mean age (SD)∗∗ 74.11 (9.7) 73.29 (9.3) 73.65 (9.3) 74.00 (9.3) 73.92 (9.6)
% male∗∗∗ 50.1% 56.2% 57.5% 58.6% 52.8%
% nonwhite∗∗∗ 11.2% 6.5% 5.3% 4.5% 9.0%
Mean number of admissions (SD)∗∗ 1.60 (1.2) 1.54 (1.0) 1.69 (1.3) 1.63 (1.3) 1.61 (1.2)
Mean hospital length of stay in days (SD)∗∗∗ 7.25 (6.7) 6.31 (5.8) 5.83 (4.5) 5.90 (4.8) 6.80 (6.2)
Mean Charlson comorbidity index (SD) 1.14 (1.4) 1.10 (1.4) 1.08 (1.3) 1.10 (1.4) 1.13 (1.4)
Mean county elevation in feet (SD)∗∗∗ 693 (1,035) 1,129 (1,280) 1,031 (1,180) 1,200 (1,264) 851 (1,136)
Mean ZIP code-based median $40,917 ($15,544) $30,941 ($6,800) $27,395 ($6,131) $26,489 ($6,517) $36,272 ($14,301)
household income (SD)∗∗∗
Asterisks indicate statistically significant differences across the 4 geographic locations: ∗P ≤ .05, ∗∗P ≤ .01, ∗∗∗P ≤ .001.
†Aggregations of Rural-Urban Commuting Areas.
Missing values: All beneficiaries: race: urban 100, large rural 20, small rural 18, isolated small rural 16; length of stay: urban 172, large rural 30, small rural
29, isolated small rural 23; ZIP code-based median household income: urban 1, large rural 0, small rural 0, isolated small rural 0. Beneficiaries who had an
oxygen claim: race: urban 24, large rural 6, small rural 6, isolated small rural 5; length of stay: urban 43, large rural 10, small rural 6, isolated small rural 9.
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Figure 1 Unadjusted Percentage of Study Patients Receiving Oxygen Supplementation.
discharge and December 31, 2000. Patients living in ru-
ral areas had higher rates of home oxygen use than those
in urban areas; however, the elevations of these rural ar-
eas, on average, were nearly twice that of the urban ar-
eas. Those living in rural areas were the most likely to be
white or male and have the shortest lengths of stay and
the lowest income. The rural-urban differences for the
subset of the cohort that had an oxygen claim were neg-
ligible, except sex. Within this subset, those living in ur-
ban areas were most likely to be male. Finally, the RUCA
groups were very similar in terms of number of admis-
sions and Charlson comorbidity scores.
Figure 1 displays a state-level analysis. In general, the
higher utilization areas were in the mountain states,
while low-utilization areas were in the eastern and south-
ern regions. There was more than a 4-fold difference be-
tween the highest and lowest utilization states. These data
can be found in Supplementary Table 1 (available online
only), which shows the percent of study patients who
used supplemental oxygen by state.
There were several HRRs that were greater than 2
SDs above or below the HRR mean unadjusted uti-
lization rates for supplemental oxygen. High-utilization
HRRs included Colorado Springs, Fort Collins, Greeley,
and Pueblo, Colorado; Idaho Falls, Idaho; Traverse City,
Michigan; Amarillo, Texas; Salt Lake City and Ogden,
Utah; and Casper, Wyoming. High-utilization states (2
SDs above the state mean unadjusted utilization rate) in-
cluded Colorado, Utah, and Wyoming (data not shown).
Only the District of Columbia was classified as a low-
utilization state (2 SDs below the mean unadjusted uti-
lization rate), while 4 HRRs—Lafayette, Louisiana; New
Brunswick, New Jersey; Grand Forks, North Dakota; and
Harlingen, Texas—fell into the low-utilization-rate cate-
gory. These data may be found in Table 2.
After adjusting for patient and contextual character-
istics (including elevation above sea level), a somewhat
different set of states and HRRs were identified as
high oxygen utilizers (2 SDs above the mean odds ra-
tio). These included the state of Alaska, as well as the
HRRs of Redding, California; Pueblo, Colorado; Lakeland,
Florida; Idaho Falls, Idaho; South Bend, Indiana; Tra-
verse City, Saginaw, Flint, and Grand Rapids, Michigan;
Cape Girardeau, Missouri; Amarillo, Texas; Ogden, Utah;
Olympia, Washington; and La Crosse, Wisconsin. After
this same adjustment, low oxygen utilization areas (2
SDs below the mean odds ratio) included the District of
Columbia and Louisiana (data not shown), but no HRRs.
These data may also be found in Table 2.
In a multivariate logistic regression analysis (Table 3)
that examined various sociodemographic, clinical, and
environmental characteristics and the use of oxygen,
patients living in large rural areas were significantly
more likely to use oxygen than patients living in urban
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Table 2 HRRs 2 SDs Above and Below the Unadjusted Mean Oxygen
Utilization Rate and the Adjusted Mean Oxygen Utilization Odds Ratio
Unadjusted % Using Oxygen N
HRR unadjusted oxygen utilization rate >2 SDs above the mean HRR
oxygen utilization rate
Ogden, UT 76.0 25
Pueblo, CO 76.0 25
Idaho Falls, ID 71.4 21
Casper, WY 63.9 36
Fort Collins, CO 62.5 32
Greeley, CO 62.5 32
Colorado Springs, CO 62.1 66
Amarillo, TX 60.7 84
Traverse City, MI 60.7 28
Salt Lake City, UT 59.7 119
HRR unadjusted oxygen utilization rate >2 SDs below the mean HRR
oxygen utilization rate
Harlingen, TX 14.8 54
New Brunswick, NJ 13.7 102
Lafayette, LA 12.0 92
Grand Forks, ND 11.4 35
HRR adjusted∗ odds ratio for oxygen utilization >2 SDs above the
mean HRR odds ratio
Ogden, UT 76.0 25
Pueblo, CO 76.0 25
Idaho Falls, ID 71.4 21
Amarillo, TX 60.7 84
Traverse City, MI 60.7 28
Lakeland, FL 53.2 62
La Crosse, WI 53.1 32
Saginaw, MI 51.9 104
Flint, MI 50.0 88
Grand Rapids, MI 50.0 114
Olympia, WA 50.0 30
South Bend, IN 47.5 99
Redding, CA 46.9 49
Cape Girardeau, MO 46.7 45
HRR adjusted∗ odds ratio for oxygen utilization >2 SDs below the
mean HRR odds ratio
None
∗Multiple logistic regression analyses adjusted for age, sex, race, number
of admissions, Charlson comorbidity index, elevation, and ZIP code-based
median household income.
areas (P = .016). Within all rural areas, patients living
in large rural areas were significantly more likely than
those in small rural areas (P = .030), but not signifi-
cantly more likely than those in isolated small rural areas
(P = .748), to use oxygen. In addition, patients who were
younger, male, white, had a higher Charlson comorbid-
ity index, a greater number of hospital admissions, and
lived at higher altitudes and in areas of greater income
had higher odds of using supplemental oxygen than their
counterparts.
Table 3 Odds of Supplemental Oxygen Use by Patient Residence Loca-
tion, Sociodemographic, Clinical, and Environmental Characteristics (n =
34,761)
Patient Characteristics Odds Ratio (CI∗) P Value
Residence location
Urban 0.91 (0.85, 0.98) .016
Large rural 1.0 (ref) —
Small rural 0.90 (0.83, 0.99) .031
Isolated small rural 0.98 (0.89, 1.09) .754
Age (years)
<65 1.46 (1.35, 1.58) .000
65-69 1.64 (1.52, 1.76) .000
70-74 1.67 (1.56, 1.78) .000
75-79 1.49 (1.40, 1.59) .000
80+ 1.0 (ref) —
Sex
Male 1.53 (1.46, 1.61) .000
Female 1.0 (ref) —
Race
White 1.57 (1.46, 1.69) .000
Nonwhite 1.0 (ref) —
Number of hospital admissions during study period
1 1.0 (ref) —
2 2.02 (1.90, 2.16) .000
3+ 3.26 (3.00, 3.53) .000
Elevation of residence location
0-500 feet 1.0 (ref) —
501-1,000 feet 1.09 (1.03, 1.15) .002
1,001-2,000 feet 1.17 (1.08, 1.26) .000
2,001-3,000 feet 1.25 (1.08, 1.44) .003
3,001-4,000 feet 1.89 (1.57, 2.27) .000
4,001+ feet 2.85 (2.48, 3.28) .000
Median household income in ZIP code
≤$20,000 1.0 (ref) —
$20,001-$25,000 1.20 (1.07, 1.35) .002
$25,001-$30,000 1.27 (1.13, 1.42) .000
$30,001-$40,000 1.37 (1.22, 1.53) .000
$40,001-$50,000 1.41 (1.26, 1.59) .000
$50,001+ 1.27 (1.12, 1.43) .000
Charlson comorbidity index
0 1.0 (ref) —
1 1.11 (1.05, 1.17) .000
2 1.05 (0.98, 1.13) .140
3+ 1.08 (1.00, 1.17) .056
∗CI, confidence interval.
Missing values: race/ethnicity 154, income 1.
Discussion
Our study reveals that over one third of all Medicare pa-
tients admitted for obstructive lung disease utilized sup-
plemental oxygen within 1 to 2 years of hospital dis-
charge. However, there is significant statewide variation
in the use of supplemental oxygen after hospitalization,
with the highest use occurring in the Rocky Mountain
states. Analysis of HRRs suggests that after controlling
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for sociodemographic, clinical, and environmental fac-
tors, some low-lying communities such as Lakeland,
Florida, and Olympia, Washington, have very high uti-
lization rates.
The unadjusted results suggest few rural/urban differ-
ences in the rates of supplemental oxygen use. However,
our controlled analysis suggests that supplemental oxy-
gen use was higher in large rural areas compared to ur-
ban areas and small rural areas. Previous studies have
shown that the medical care received in large rural ar-
eas is similar in quality to that of urban areas. For ex-
ample, Rosenblatt et al found that patients living in large
remote rural areas received the highest quality diabetes
care,22 while Stearns et al found that those in large rural
areas reported the highest rates of satisfaction with care
anywhere.23 Additional research has demonstrated that
patients receiving care from hospitals in large rural ar-
eas generally had guideline adherence rates for acute my-
ocardial infarction close to that of urban areas.8 There are
several explanations for such findings. Many of the large
rural towns/cities are vital economic entities with grow-
ing populations, and their hospitals are referral sites for
the surrounding areas. These rural towns/cities of 10,000
to 49,000 often have an adequate supply of both primary
care and specialty care physicians along with the associ-
ated medical infrastructure.
There are several limitations to our findings. First, we
defined our cohort through an initial hospitalization. Our
findings may not generalize to those individuals who
started supplemental oxygen as an outpatient. In addi-
tion, we had limited data on patient severity of illness.
Because we were dealing with administrative data, we
had no specific measures of pulmonary function. Thus,
we were forced to infer patient severity of illness by con-
trolling for the number of hospital admissions and patient
length of stay. Another limitation is the small sample size
in many of the HRRs, resulting in oxygen supplementa-
tion rates with very large confidence intervals. For this
reason, we present results only for those HRRs above
or below 2 SDs from the mean oxygen supplementation
rates. We do not have any data on patient outcomes. Al-
though we have documented that significant variation
in supplemental oxygen utilization exists between geo-
graphic areas, it is unclear what the appropriate rate of
supplemental oxygen utilization is after hospitalization
for obstructive lung disease.14,24
To add to the robustness of our modeling, we per-
formed additional sensitivity analyses, which included a
measure of air pollution as well as state as a fixed effect
in our multivariate regression analysis. Using a methodol-
ogy described previously, we identified patient exposure
to particulate matter less than 2.5 μm on aerodynamic
diameter, based on ZIP code.25 Particulate matter less
than 2.5 μm was chosen as it is an air pollutant that has
been linked to mortality.25 Particulate matter less than
2.5 μm data were collected by the Environmental Protec-
tion Agency and were available for the year 2000. Pa-
tients were included if they were within 100 miles of
an air pollution monitor, which required us to drop 569
(1.6%) subjects. Our main findings did not change in
these secondary regression analyses, and thus only the
original results are displayed.
Despite these limitations, this study has important im-
plications. To our knowledge, this is the first time geo-
graphic differences in the utilization of supplemental oxy-
gen have been examined in detail. While we failed to
find dramatic rural/urban differences in oxygen utiliza-
tion, the reasons for this need to be investigated further.
If indeed supplemental oxygen is delivered in a manner
that is less related to rural location, it may be a model
for other types of service delivery where rural location
is an issue. In addition, we have identified significant
variations between states and HRRs. Given that there is
an over 4-fold difference between the high- and low-
utilization states and an over 6-fold difference between
high- and low-utilization HRRs, that urban and small ru-
ral areas have the lowest adjusted oxygen use rates, and
that CMS pays nearly $2 billion per year for these ser-
vices, further examination of why these variations exist
is warranted. This investigation should include an assess-
ment of practice guidelines, as well as ways to reduce
administrative complexity and fraud. CMS, through its
Quality Improvement Organizations and Durable Medical
Equipment Regional Carriers, has the means to examine
these issues in detail and enact changes that will improve
both patient health and fiscal responsibility.
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